Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s Reassessment and Uptake Working Group
Dai, Wei Fang, Arciero, Vanessa, Craig, Erica, Fraser, Brent, Arias, Jessica, Boehm, Darryl, Bosnic, Nevzeta, Caetano, Patricia, Chambers, Carole, Jones, Barry, Lungu, Elena, Mitera, Gunita, Potashnik, Tanya, Reiman, Anthony, Ritcher, Trevor, Beca, Jaclyn M., Denburg, Avram, Mercer, Rebecca E., Parmar, Ambica, Tadrous, Mina, Takhar, Pam, Chan, Kelvin K. W.
Published in Current oncology (Toronto) (16.10.2021)
Published in Current oncology (Toronto) (16.10.2021)
Get full text
Journal Article